Flint Development wins Spotsylvania County approval for Patriot 95 logistics facility in Thornburg, VA
Acumatica 2026 R1 brings AI-driven project risk tools to construction ERP as margin pressure intensifies
Why NUBURU, Inc.’s Phase I activation with Maddox Defense matters for U.S. defense supply-chain resilience (NYSE American: BURU)
Read More 8 minute read Pharma Industry News Gilead Sciences bets $2.2bn on immune reset with Ouro Medicines BCMAxCD3 bispecific acquisition Gilead Sciences agrees to acquire Ouro Medicines for up to $2.175bn, adding BCMA T cell engager gamgertamig to its inflammation pipeline. Read the full strategic analysis. byVenkateshMarch 24, 2026